Smith v. E R Squibb & Sons, Inc

This product liability case arose from the acute anaphylactic (extreme hypersensitivity) reaction resulting in the death of Shirley Smith which occurred when Renografin-60, a product of defendant E. R. Squibb & Sons, Inc., was injected into her blood stream. Such sensitivity is extremely rare and cannot be discovered prior to injection. It is undisputed and clearly reflected in the record that there was no intrinsic defect in the drug.

Plaintiff named the drug manufacturer, various *85doctors and the hospital as defendants in the action. Upon trial by jury, one doctor received a directed verdict…